Stocks
USANA Health Sciences (USNA) EBITDA margin US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | 16.3% | 13.0% | 13.4% | 11.6% | 8.87% | 8.46% | ||
| Changes by years, y/y, % | -1pp | -3pp | +0pp | -2pp | -3pp | -12.9% | |||
USANA Health Sciences. EBITDA margin, %
USANA Health Sciences. EBITDA margin, changes, pp
USANA Health Sciences (USNA) EBITDA margin US GAAP (quarter values) |
||||||||
| FY2025Q3 | FY2025Q4 | FY2026Q1 | FY2026Q2 | FY2026Q2 | LTM ? | |||
| EBITDA margin, % | ? | 5.34% | 6.45% | 10.2% | -8.46% | -8.46% | 8.46% | |
| Changes by years, y/y, % | -7pp | -1pp | -1pp | -21pp | -21pp | |||
| Changes by quarters, q/q, % | -7pp | +1pp | +4pp | -19pp | 0pp | |||
